Effect of cardiovascular risk factors on left ventricular ejection fraction in HER2 positive breast cancer patients who were treated in adjuvant setting with trastuzumab

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms Cardiotoxicity of Drugs and Other Therapies ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by